Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Just For You Oklo: The Bottom Is In, and the Upside Potential Is NuclearSubmitted by Thomas Hughes. First Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
Oklo Inc. (NYSE: OKLO) faces headwinds, including a lack of revenue and profitability, but investors appear unconcerned. The company's fiscal year 2025 (FY2025) progress report and updates indicate it remains on track to meet long-term goals and market expectations. Analyst reactions to the release underscore the market's focus on the long-term opportunity rather than near-term revenue. Analysts Focus on Oklo's Long-Term Opportunity MarketBeat tracked about half a dozen analyst revisions within the first 12 hours after the release. Those moves included a single price-target reduction, offset by a larger number of affirmed ratings and targets — and no downgrades. Amazon, Google, Meta, and Microsoft have collectively committed nearly 700 billion dollars to technology infrastructure this year alone. Bloomberg called it 'a boom without a parallel this century.' That capital doesn't stay with the giants - it flows through hundreds of smaller companies supplying chips, software, data, and infrastructure. Chris Rowe has identified the small-cap stocks he believes are positioned directly in its path. Watch the free presentation and see the specific stocks Chris identified The activity is consistent with an established trend: increasing coverage, a steady Moderate Buy rating, a 58% Buy-side bias, and an upward trajectory in price targets. Those targets are important because, at consensus, they imply more than 50% upside from mid-March lows. While analysts expressed concern about the 2025 results, they remain more focused on Oklo's long-term opportunity and progress with Nuclear Regulatory Commission licensing. The company received its first license, granted to its isotope-producing subsidiary Atomic Alchemy. The license permits receipt, possession, storage, processing, repackaging and distribution of up to two curies of radium-226 — roughly two grams. Two grams isn't much, and radium-226 alone is not especially valuable. It was once commonly used in medical applications but is now a nuisance to handle and remediate. Demand is rising, however, because radium-226 is the source material for actinium, one of the most expensive elements, used in specialized cancer treatments that can cost roughly $20,000 per dose. The takeaway for investors is that Oklo's diversification strategy has been validated and an initial revenue stream has been opened. It may take a few quarters for meaningful revenue to flow, but that income likely arrives well before the full commercialization of its core nuclear reactor technologies. Institutional and Short-Selling Data Reveal the Bottom is In for Oklo Stock Institutional and short-interest data suggest the stock has put in a bottom. Short interest remains elevated — near 15% as of early March — but it is down from its peak following Oklo's October 2025 highs and is likely to decline further in upcoming reports. Institutional activity has moved the other direction, ramping up after Oklo's Q2 2025 plunge and reaching record levels in early 2026.  As it stands, institutional investors own about 85% of the stock, provide solid support, and are accumulating at roughly $3 bought for every $1 sold. If these trends continue, the number of available shares will shrink appreciably over the coming months, creating scope for upward price movement — and raising the possibility of a short squeeze if a catalytic news event occurs. Dilutive Headwinds Cease in 2026 Shareholder dilution was a material issue in 2025 but has eased in 2026. The company's share count is up roughly 50% year over year, and the balance sheet is well capitalized. FY2026 plans suggest sufficient capital for about two years at the current project burn rate, which should provide a window for secondary revenue streams, like the isotope business, to mature. The trade-off is that profitability isn't expected until 2030, implying additional capital will likely be required down the road. The technical setup is encouraging. OKLO's stock is far below its highs and appeared overextended at mid-March levels. The MACD has diverged and turned bullish, and the stochastic has followed suit, signaling a strong buy at current levels. Whether the market follows through remains to be seen, and it may take time to gain traction. Even with a constructive outlook, the lack of current revenue and profits is a significant burden for the market to price. The largest risk is execution and delay. The market is valuing the stock on a robust growth outlook — more than 100 times its initial-year earnings — and may be intolerant of material setbacks. In that scenario, Oklo could face heightened volatility regardless of when the rebound gains momentum. | 
